Osteoarthritis Market, [By Therapeutic Type (Analgesic, Hyaluronic Acid, Non-steroidal anti-inflammatory Drugs, Corticosteroids); By Disease Type (Spine, Knee, Foot & Ankle, Shoulder, Hand); By End Users (Retail Pharmacy, Hospital Pharmacy, Drug Store, E-commerce)]; and Geography - Trend, Analysis and Forecast till 2025

Report Summary

The Global osteoarthritis Market Size is majorly driven by factors such as prevalence of osteoarthritis in the geriatric population, and rising need and demand for proper treatment of osteoarthritis across the globe.

骨关节炎被认为是最常见的关节炎类型，影响全球数百万人。它可以定义为大多数影响人体中关节的疾病，并且是由手，膝盖，脊柱和臀部的关节中的炎症，分解和软骨丧失引起的。这也称为退行性关节炎。这种疾病的主要患病率在老年人口中发现。骨关节炎平均影响了10％的男性和12％以上的女性患者60岁。它是一种无常常治愈的进步疾病，但可以在止痛药的帮助下控制它的痛苦和肿胀，帮助个人留下移动并进行正常活动。

Osteoarthritis normally begins after the age of 40 years, but can affect the younger people after traumatic injury. This is a chronic degenerative disorder that results in biochemical breakdown of the cartilages in the synovial joints. The wear and tear of the tissues over the time is one of the major cause of osteoarthritis. This disorder is majorly characterised by pain, stiffness, loss of flexibility, tenderness, and bone spurs. With no proper cure to this disorder the major painkillers are used for reducing the intensity of pain caused due to this disorder. Moreover, staying active by maintaining healthy weight by regular exercising and stretching may slow down the progression of this disorder and help in improving the pain and joint function. While, continuous increase in the number of phase III drugs such as Invossa, and Ampion would also influence the market in the near future.

Rising need for effective treatment for Osteoarthritis, and increased pipeline analysis for developing innovative products for treating osteoarthritis will support the growth of global osteoarthritis market.

市场主要是由于在全球患骨关节炎的患者越来越多的患者。For instance, approximately 27 million people in the U.S. alone which is one of the major reason that has increased disability in the U.S. Additionally, increased number of chronic disorder such as diabetes, & cardiovascular diseases, and increasing preference for the sedentary lifestyle that reduces the movement of the body would add on the growth of this market during the forecast period. Moreover, rising prevalence of geriatric population would also spur the market in the near future. According to National Institute of Health, the aging population is projected to increase by 17% (1.6 billion) total population by 2050.

Furthermore, increasing number of clinical trials for developing new drugs to propel the growth of this industry in the near future and rising demand for cost-effective diagnostic techniques to boost the osteoarthritis market.

然而，对治疗骨关节炎的疾病和未满足的需求没有适当治愈可能会阻碍在不久的将来的这种市场的增长。

Global Osteoarthritis Market Taxonomy

全球市场基于治疗类型和地理分段。

在治疗类型的基础上，市场被分段为

• Analgesic
• 透明质酸
• Non-steroidal Anti-inflammatory Drugs
• Corticosteroids

On the basis of disease type, market is segmented into

• Spine
• Knee
• 脚和脚踝
• Shoulder
• E-commerce

On the basis of disease type, market is segmented into

• Retail Pharmacy
• Hospital Pharmacy
• Drug Store
• E-Commerce

Geographically, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

增加支出on R&D for developing new and effective treatments and changing lifestyle to lead the osteoarthritis market growth in North America.

North America region is expected to dominate the global osteoarthritis market over the forecast period. North America holds major share owning to the continuous technological developments along with the strong presence of key players and the increasing R&D investments by these players and government. Additionally, increasing awareness for the use of biological therapies would also spur the market in North America. Moreover, geriatric population, and increased sedentary lifestyle preference would also support the market growth.

However, Asia Pacific is expected grow at a faster pace during the forecast period. Increasing number of patients suffering from osteoarthritis & other chronic diseases that cause osteoarthritis, changing lifestyle, and rising preference for sedentary lifestyle are the major factor anticipated to govern the market during upcoming years.

全球骨关节炎市场的主要球员是

• Pfizer AG
• 诺华AG
• Johnson & Johnson Inc.
• GlaxoSmithKline plc.
• Eli Lily Company
• Ampio Pharmaceuticals Inc.
• 生物联倍科学国际，Inc。
• 雅培实验室
• 辐孔制药水疗中心
• Merck & Company
• Sonafi Pasture
• 温斯顿药业